Program Description: 

We discuss and present new patients diagnosed with hematologic malignancies, their underlying biology and risk stratification, treatment plan, predicted results in addition to those patients with relapse/refractory disease. We discuss new therapies, clinical trials, diagnostic dilemmas. We review biology, molecular and cytogenetic findings, flow cytometry and morphology.

Target audience: 
  • Physicians
  • Nurse Practitioners
  • Physician Assistant
  • Nurses
  • Research Staff
Learning objectives: 

Participants who engage in this educational intervention will be able to:

  • Assess patients diagnosed with hematologic malignancies, their underlying biology and risk stratification, treatment plan, predicted results 
  • Describe new therapies, clinical trials, diagnostic dilemmas
  • Review biology, molecular and cytogenetic findings, flow cytometry and morphology.
Faculty & credentials: 

In accordance with the ACCME® Standards for Integrity and Independence in Accredited Continuing Education, Standard 3, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.

Michael J. Burke, MD
Professor
Director, Leukemia & Lymphoma Program
Co-Director, Developmental Therapeutics Program
Children’s Hospital of Wisconsin
Medical College of Wisconsin

Contact

Name: 
Alicia Copp
Phone number: 
+1 (414) 955-4170

Accreditation Statement

The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians

Designation of Credit Statement

The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

Hours of Participation for Allied Health Professionals

The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.

MOC Part II

Successful completion of this CME activity, which includes participation in the activity and individual assessment of and feedback to the learner, enables the learner to earn up to 1 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.

Participation shared with ABP through PARS:

Individual participants’ information will be shared with ABP through the ACCME Program and Activity Reporting System (PARS). 

Session date: 
10/04/2023 - 3:00pm to 4:00pm CDT
Location: 
Hybrid Meeting
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.